Evolent Health Inc

EVH

Equity

ISIN US30050B1017 / Valor 28153126

New York Stock Exchange, Inc (2024-09-18)

USD 30.84+0.98%

Evolent Health Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Evolent Health Inc is a healthcare technology and services company that partners with health systems to help them transition to value-based care.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Evolent Health Inc. reported a revenue of $647.1 million for the second quarter of 2024, marking an increase of $178.0 million or 37.9% compared to the same period in 2023. This significant growth underscores the company's expanding market presence and successful business strategies.

Net Loss

For the quarter ended June 30, 2024, Evolent Health Inc. recorded a net loss attributable to common shareholders of $(6.4) million, with a net loss margin of (1.0)%. This is a notable improvement from the net loss of $(41.4) million reported in the same quarter of the previous year.

Adjusted EBITDA

Evolent Health Inc. achieved an Adjusted EBITDA of $52.0 million in Q2 2024, resulting in an Adjusted EBITDA margin of 8.0%. This reflects a steady performance compared to the Adjusted EBITDA of $47.4 million in Q2 2023, despite the margin decrease from 10.1%.

Revenue Outlook

The company has narrowed its revenue outlook for the full year 2024, now expecting revenue to be in the range of approximately $2.56 billion to $2.60 billion. This adjustment reflects the company's strategic focus on setting appropriate rates and managing partnership dynamics with payers.

Full Year Guidance

For the year ending December 31, 2024, Evolent Health Inc. has provided an updated Adjusted EBITDA guidance range of $230.0 million to $245.0 million. The company remains confident in achieving a $300 million Adjusted EBITDA run rate by the end of 2024, driven by strong sales performance and clinical value delivery.

Summarized from source with an LLMView Source

Key figures

16.0%1Y

16.6%3Y

291%5Y

Performance

52.3%1Y

48.9%3Y

63.2%5Y

Volatility